Otros idiomas Avalo Therapeutics, Inc.

Acciones

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:00 31/05/2024			Varia. Cinco días.	Varia. 1 de enero.
11,68 ^USD	-0,55 %		-10,80 %	+28,41 %

13/05	Avalo Therapeutics, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
16/04	AVALO THERAPEUTICS, INC. : De neutro a compra por Oppenheimer	ZM

Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
AVALO THERAPEUTICS, INC. : Oppenheimer passe à l'achat	16/04
Avalo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Sector Update: Health Care Stocks Rise Late Afternoon	28/03
Top Midday Gainers	28/03
Wall Street Set to Open Flat in Thursday Trading; Q4 US GDP Revised Up, Weekly Jobless Claims Fall	28/03
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	28/03
US Futures Little Changed Pre-Bell Thursday Ahead of Raft of Economic Data	28/03
Top Premarket Gainers	28/03
Avalo Therapeutics, Inc. acquired AlmataBio, Inc. for $42.5 million.	28/03
Avalo Therapeutics Shares Triple After Acquisition of AlmataBio, Private Placement Financing of Up to $185 Million	27/03
Avalo Therapeutics, Inc. Announces Board Appointments	27/03
Avalo Therapeutics Plans 1-for-240 Reverse Stock Split	27/12
Avalo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Top Midday Gainers	12/09/23
Avalo Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03/08/23
AVALO THERAPEUTICS, INC. : Oppenheimer moins optimiste	27/06/23
AVALO THERAPEUTICS, INC. : RBC Capital Markets dégrade son opinion à neutre	27/06/23
Top Midday Decliners	26/06/23
Avalo Says Trial of AVTX-002 to Treat Non-Eosinophilic Asthma Did Not Meet Primary Endpoint; Shares Slump	26/06/23

No hay resultados para esta búsqueda